1887

Abstract

Transient transfections of tissue culture cells with plasmids encoding the transactivating factors MHBs and HBx of hepatitis B virus result in transcriptional stimulation of multiple target genes. Our experiments show that the NF-κB-binding enhancer element of simian virus 40 (SV40) and the AP-1-binding enhancer element of the human metallothionein IIA gene mediate the transactivating function of MHBs and HBx. In contrast, the elements GT(IIC+I) and Sph(II+I) of the SV40 enhancer, that, as a common feature, require binding of transcription factor TEF-1 for activity, efficiently mediate transactivation only by HBx but not by MHBs. This finding suggests that at least one regulatory pathway exists that can only be activated by HBx but not by MHBs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-4-1033
1995-04-01
2022-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/4/JV0760041033.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-4-1033&mimeType=html&fmt=ahah

References

  1. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. 1987; Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739
    [Google Scholar]
  2. Arii M., Takada S., Koike K. 1992; Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7:397–403
    [Google Scholar]
  3. Beasley R. P. 1988; Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942–1956
    [Google Scholar]
  4. Caselmann W. H., Meyer M., Kekulé A. S., Lauer U., Hofschneider P. H., Koshy R. 1990; A transactivator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma. Proceedings of the National Academy of Sciences, USA 87:2970–2974
    [Google Scholar]
  5. Chang R. S. 1954; Continuous subcultivation of epithelial-like cells from normal human tissues. Proceedings of the Society of Ex perimental Biology and Medicine 87:440–443
    [Google Scholar]
  6. Davidson I., Xiao J. H., Rosales R., Staub A., Chambon P. 1988; The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54:931–942
    [Google Scholar]
  7. Fromental C., Kanno M., Nomiyama H., Chambon P. 1988; Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell 54:943–953
    [Google Scholar]
  8. Ganem D., Varmus H. E. 1987; The molecular biology of the hepatitis B viruses. Annual Reviews in Biochemistry 56:651–693
    [Google Scholar]
  9. IsHiji T., Lace M. J., Parkinnen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J.-H., Davidson I., Chambon P., Turek L. P. 1992; Transcriptional enhancer factor (TEF-1) and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO Journal 11:2271–2281
    [Google Scholar]
  10. Kanno M., Fromental C., Staub A., Ruffenach F., Davidson I., Chambon P. 1989; The SV40 TC-II(kB) and the related H-2KB enhansons exhibit different cell type specific and inducible proto enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO Journal 8:4205–4215
    [Google Scholar]
  11. Kekulé A. S., Lauer U., Meyer M., Caselmann W. H., Hofschneider P. H., Koshy R. 1990; The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457–461
    [Google Scholar]
  12. Kekulé A. S., Lauer U., Weiss L., Luber B., Hofschneider P. H. 1993; Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742–745
    [Google Scholar]
  13. Kim Y.-H., Kang S.-K., Lee Y. I. 1993; Functional analysis of the hepatitis B virus transactivator X: implication of the leucine zipper like region and C-terminal seven conserved amino acids in functional regions. Biochemical and Biophysical Research Communications 197:894–903
    [Google Scholar]
  14. Koch W., Benoist C., Mathis D. 1989; Anatomy of a new B-cell-specific enhancer. Molecular and Cellular Biology 9:303–311
    [Google Scholar]
  15. Koshy R., Meyer M. 1992; Oncogenicity of hepatitis B virus. Reviews in Medical Virology 2:131–140
    [Google Scholar]
  16. Kwee L., Lucito R., Aufiero B., Schneider R. J. 1992; Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. Journal of Virology 66:4382–4389
    [Google Scholar]
  17. Lauer U., Weiss L., Hofschneider P. H., Kekulé A. S. 1992; The hepatitis B virus pre-S/S′ transactivator is generated by 3′ truncations within a defined region of the S gene. Journal of Virology 66:5284–5289
    [Google Scholar]
  18. Lee W., Haslinger A., Karin M., Than R. 1987; Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325:368–372
    [Google Scholar]
  19. Luber B., Bürgelt E., Fromental C., Kanno M., Koch W. 1991; Multiple simian virus 40 enhancer elements mediate the trans-activating function of the X protein of hepatitis B virus. Virology 184:808–813
    [Google Scholar]
  20. Macchi M., Bornert J.-M., Davidson I., Kanno M., Rosales R., Vigneron M., Xiao J.-H., Fromental C., Chambon P. 1989; The SV40 TC-II (kB) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non lymphoid cell lines. EMBO Journal 8:4215–4227
    [Google Scholar]
  21. Maguire H. F., Hoefler J. P., Siddiqui A. 1991; HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842–844
    [Google Scholar]
  22. Meyer M., Caselmann W. H., Schluter V., Schreck R., Hof schneider P. H., Baeuerle P. A. 1992; Hepatitis B virus transactivator MHBs1: activation of NF-kB, selective inhibition by antioxidants and integral membrane localization. EMBO Journal 11:2991–3001
    [Google Scholar]
  23. Mitchell P. J., Wang C., Than R. 1987; Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50:847–861
    [Google Scholar]
  24. Nomiyama H., Fromental C., Xiao J. H., Chambon P. 1987; Cell-specific activity of the constituent elements of the simian virus 40 enhancer. Proceedings of the National Academy of Sciences, USA 84:7881–7885
    [Google Scholar]
  25. Renner M., Haniel A., Bürgelt E., Hofschneider P. H., Koch W. 1995; Transactivating function and expression of the x gene of hepatitis B virus. Journal of Hepatology (in press)
    [Google Scholar]
  26. Ritter S. E., Whitten T. M., Quets A. T., Schloemer R. H. 1991; An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity. Virology 182:841–845
    [Google Scholar]
  27. Rosales R., Vigneron M., Macchi M., Davidson I., Xiao J. H., Chambon P. 1987; In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers. EMBO Journal 6:3015–3025
    [Google Scholar]
  28. Seto E., Mitchell P. J., Yen T. S. B. 1990; Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74
    [Google Scholar]
  29. Tiollais P., Pourcel C., Dejean A. 1985; The hepatitis B virus. Nature 317:489–195
    [Google Scholar]
  30. Tooze J. 1982; DNA tumor viruses. In Molecular Biology of Tumor Viruses 2nd edn., part 2, revised New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  31. Twu J.-S., Schloemer R. H. 1987; Transcriptional transactivating function of hepatitis B virus. Journal of Virology 61:3448–3453
    [Google Scholar]
  32. Wollersheim M., Debelka U., Hofschneider P. H. 1988; A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545–552
    [Google Scholar]
  33. Xiao J. H., Davidson I., Matthes H., Garnier J.-M., Chambon P. 1991; Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551–568
    [Google Scholar]
  34. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X-ORF encodes a transactivator: a potential factor in viral hepato-carcinogenesis. Oncogene 3:169–177
    [Google Scholar]
  35. Zenke M., Grundström T., Matthes H., Wintzerith M., Schatz C., Wildeman A., Chambon P. 1986; Multiple sequence motifs are involved in SV40 enhancer function. EMBO Journal 5:387–397
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-4-1033
Loading
/content/journal/jgv/10.1099/0022-1317-76-4-1033
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error